venBio Select Advisor LLC, 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 650,000 shares at $13.00 ($8.4M) on 2017-11-16, disclosed to the SEC on 2017-11-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |